explore -WSS

explore

author：knowledge 2025-09-06 04:38:21 - browse：65

Nuance Image Gallery

Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to embed the technology in health systems nationwide.

The AI product, DAX Copilot, will automatically draft notes through Epic’s mobile application, known as Haiku, making it available for immediate review by clinicians. The tool is designed to streamline clinician note taking, a laborious process that has become a common source of complaint within health systems.

DAX Copilot is already used by hundreds of hospitals and clinics, but its availability through Epic significantly expands its reach and availability to potential users. Epic is the nation’s largest seller of software used to record and analyze patient health records.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Obesity drugs seen as possible treatment for liver disease MASH

WSS

R1 RCM gets $5.8 billion buyout offer from private equity firm

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

One Duchenne patient's bittersweet hope for new treatment

Alabama hospital puts IVF treatments on hold

In utero gene editing: an explainer

Inflation cooled significantly in June, bringing price hikes close to normal levels

focus

explore

Wikipedia

Heart attack and stroke risk calculators need revising

One Duchenne patient's bittersweet hope for new treatment

Hepatitis C has a cure — but many Americans still lack access to it

He's a Nobel laureate. Critics say he was misleading on Covid

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Superbugs, antibiotic resistance get scrutiny in congress

United colonoscopy coverage change 'may cost lives,' doctors say

Obesity drugs seen as possible treatment for liver disease MASH

Peter Hotez and the public health issue of online harassment

R1 RCM gets $5.8 billion buyout offer from private equity firm

leisure time

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Obesity drugs seen as possible treatment for liver disease MASH

NIH study of ME/CFS points to clear biological hallmarks

STAT readers on older presidents, polypills, Medicare, and more

knowledge

explore

hotspot

explore